Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry for Molecular Testing, Treatment and Outcome of Patients With Locally Advanced or Metastatic Solid Tumors Harboring a Fusion of NTRK1, NTRK2 or NTRK3

NCT04557813 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT04557813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04557813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry for Molecular Testing, Treatment and Outcome of Patients With Locally Advanced or Metastatic Solid Tumors Harboring a Fusion of NTRK1, NTRK2 or NTRK3
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
December 2, 2020
Completion date
December 31, 2024
Enrollment
88 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

ntrk family gene mutation